The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients.
Autor: | Gane, Edward J.1 EdGane@adhb.govt.nz, Weilert, Frank2, Orr, David W.1, Keogh, Geraldine F.3, Gibson, Michael3, Lockhart, Michelle M.3, Frampton, Christopher M.4, Taylor, Kenneth M.3, Smith, Robin A. J.5, Murphy, Michael P.6 |
---|---|
Zdroj: | Liver International. Aug2010, Vol. 30 Issue 7, p1019-1026. 8p. 2 Charts, 4 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |